Oliver Lyth

Oliver Lyth, PhD, is an Associate in the M Ventures Biotechnology team having joined in 2024. Oliver holds an MBiochem from the University of Oxford and completed his PhD in Molecular Parasitology at Imperial College where his research centred on how the malaria parasite infects red blood cells. Previously, Oliver acted as an Analyst in the due diligence team supporting LifeArc Ventures before joining IP Group’s Life Sciences Partnership as an Investment Manager where he led deal flow and diligence activities for the review of Biotech investment opportunities with a focus on therapeutics. Oliver is based in London and Amsterdam.